60 Degrees Pharmaceuticals - Plans to File a New Drug Application With FDA in Q2 of 2026 for a Supplemental Indication for Tafenoquine in Babesiosis
60度药品公司-计划在2026年Q2向FDA提交新药申请,用于Tafenoquine的蚊瘤病的补充适应证
60 Degrees Pharmaceuticals - Plans to File a New Drug Application With FDA in Q2 of 2026 for a Supplemental Indication for Tafenoquine in Babesiosis
60度药品公司-计划在2026年Q2向FDA提交新药申请,用于Tafenoquine的蚊瘤病的补充适应证
使用浏览器的分享功能,分享给你的好友吧